US authorities probing several other drugmakers amid pricing row.
About Richard Staines
Posts by Richard Staines:
Concerns following event on HAVEN1 trial.
Tafinlar and Mekinist looks set for approval in BRAF V600 lung cancer
Roche rival has Breakthrough Therapy status.
Four in ten EEA doctors considering quitting, says survey.
Activist investor’s intervention adds to buzz surrounding BMS.
More rare disease drugs must also be approved, says EURORDIS.
Roche’s top seller faces rival four years after patent expiry
Antibody-drug conjugate with FDA gets six-month review.